Breaking Access Barriers to Autologous Stem Cell Transplant and Chimeric Antigen Receptor T Cell therapy in Hematological Malignancies - an ASTCT-NMDP ACCESS Initiative [0.03%]
ASTCT-NMDP ACCESS计划：消除自身干细胞移植和嵌合抗原受体T细胞治疗血液系统恶性肿瘤障碍的倡议
Pashna N Munshi,Carrie Yuen,Taha Al-Juhaishi et al.
Pashna N Munshi et al.
Autologous stem cell transplant (ASCT) and chimeric antigen receptor T cell therapy (CAR T) are approved treatments both with curative potential and/or excellent response rates in patients with aggressive hematologic malignancies. However, ...
Clinical characteristics and treatment outcomes of autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation [0.03%]
allo-HSCT后自身免疫性肝炎的临床特点和治疗结局
Daichi Kishi,Yoshimitsu Shimomura,Daisuke Yamashita et al.
Daichi Kishi et al.
Background: Liver dysfunction is a frequent complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). It may occur in both the early and late post-transplantation phases, with distinct etiologies....
Innovations in Hematopoietic Stem Cell Transplants in Low and Middle-Income Countries: A Mexican Perspective [0.03%]
低收入和中等收入国家造血干细胞移植创新的墨西哥视角
Guillermo J Ruiz-Argüelles,Juan Carlos Olivares-Gazca,Sergio Giralt et al.
Guillermo J Ruiz-Argüelles et al.
Simultaneous NOD1 and NOD2 Deletion in Hematopoietic Stem and Progenitor cells Promotes Long-Term Donor Chimerism [0.03%]
造血干细胞和祖细胞中NOD1和NOD2的同时缺失促进长期供者嵌合体形成
A A Hawkes,S G Kasimsetty,H Li et al.
A A Hawkes et al.
Background: Hematopoietic stem cell transplantation (HSCT) remains limited by inefficient donor cell engraftment, which is influenced by inflammatory stress responses triggered during conditioning and immune reconstitutio...
Bone marrow transplantation from matched and mismatched unrelated donors with post-transplant cyclophosphamide for patients with severe aplastic anemia [0.03%]
mismatched无关供者移植后使用环磷酰胺治疗重症再生障碍性贫血的安全性和有效性
Juan Montoro,Aitana Balaguer-Roselló,Pedro Chorao et al.
Juan Montoro et al.
Comment on Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers [0.03%]
关于CAR-T细胞相关炎症毒性的管理实践的评论：一项针对儿科CAR-T细胞提供者的调查
Stephan A Grupp
Stephan A Grupp
Keith M Sullivan
Keith M Sullivan
Vitamin D Deficiency and Efficacy of Supplementation in Patients Undergoing Hematopoietic Stem Cell Transplantation [0.03%]
造血干细胞移植患者中的维生素D缺乏及其补充疗效
Hilary M Winthrop,Yan Li,Delaney Underwood et al.
Hilary M Winthrop et al.
Allogeneic Hematopoietic Cell Transplantation for Morquio A Syndrome: An International Retrospective Study of 41 Children [0.03%]
莫奎奥综合征患儿异基因造血干细胞移植的国际多中心回顾性研究（41例报告）
Sandhya Kharbanda,Emma Cho,Jing Chen et al.
Sandhya Kharbanda et al.
Background: Mucopolysaccharidosis IV A (MPS IVA) or Morquio A Syndrome is a lysosomal storage disorder, which results from a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), causing deposition of glycosami...